As of 2026-01-02, the Relative Valuation of TG Therapeutics Inc (TGTX) is 23.97 USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.81 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -19.6%.
The range of the Relative Valuation is 2.84 - 49.88 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 17.7x | 15.5x |
| Forward P/E multiples | 18.0x - 36.0x | 27.0x |
| Fair Price | 2.84 - 49.88 | 23.97 |
| Upside | -90.5% - 67.3% | -19.6% |
| Date | P/E |
| 2025-12-31 | 10.58 |
| 2025-12-30 | 10.56 |
| 2025-12-29 | 10.83 |
| 2025-12-26 | 10.92 |
| 2025-12-24 | 11.03 |
| 2025-12-23 | 10.90 |
| 2025-12-22 | 11.04 |
| 2025-12-19 | 10.99 |
| 2025-12-18 | 10.62 |
| 2025-12-17 | 11.05 |
| 2025-12-16 | 10.93 |
| 2025-12-15 | 11.15 |
| 2025-12-12 | 11.12 |
| 2025-12-11 | 11.36 |
| 2025-12-10 | 10.86 |
| 2025-12-09 | 10.80 |
| 2025-12-08 | 10.94 |
| 2025-12-05 | 10.92 |
| 2025-12-04 | 11.14 |
| 2025-12-03 | 11.22 |
| 2025-12-02 | 10.87 |
| 2025-12-01 | 11.24 |
| 2025-11-28 | 11.80 |
| 2025-11-26 | 11.86 |
| 2025-11-25 | 11.70 |
| 2025-11-24 | 11.37 |
| 2025-11-21 | 11.34 |
| 2025-11-20 | 10.81 |
| 2025-11-19 | 10.76 |
| 2025-11-18 | 11.08 |
| 2025-11-17 | 10.89 |
| 2025-11-14 | 11.00 |
| 2025-11-13 | 10.99 |
| 2025-11-12 | 11.00 |
| 2025-11-11 | 11.04 |
| 2025-11-10 | 10.75 |
| 2025-11-07 | 11.44 |
| 2025-11-06 | 11.80 |
| 2025-11-05 | 12.08 |
| 2025-11-04 | 12.00 |
| 2025-11-03 | 11.96 |
| 2025-10-31 | 12.34 |
| 2025-10-30 | 12.07 |
| 2025-10-29 | 11.99 |
| 2025-10-28 | 12.26 |
| 2025-10-27 | 11.96 |
| 2025-10-24 | 11.83 |
| 2025-10-23 | 11.88 |
| 2025-10-22 | 12.27 |
| 2025-10-21 | 12.50 |